FIG 1.
CONSORT diagram of the STO-5 trial. aSeven hundred thirty-one patients with immunohistochemistry assessment. CMF, cyclophosphamide, methotrexate, and fluorouracil; ER, estrogen receptor; RT, radiotherapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.